APO RESEARCH · REPORT
Artificial Blood Substitute
Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.
Product & engineering
Understand the product.
Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.
Selected research
Industry Research
Artificial Blood Substitute Industry Research Report 2026
Market perspective
Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.
Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.
Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .
Read the full market overview
Report Scope
This report quantifies the global Artificial Blood Substitute market in terms of revenue (US$ million) and, where applicable, service volume (Kilotons), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Kilotons) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Artificial Blood Substitute.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artificial Blood Substitute Market by Company
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
Artificial Blood Substitute Segment by Type
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Artificial Blood Substitute Segment by Application
Military
Civil
Artificial Blood Substitute Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Substitute market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Substitute and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Substitute.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Artificial Blood Substitute companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Perfluorocarbon-based Oxygen Carrier (PFBOC)
- Hemoglobin-based Oxygen Carrier (HBOC)
Applications
- Military
- Civil
Companies covered
- Aurum Biosciences Ltd.
- HEMARINA SA
- HbO2 Therapeutics
- KaloCyte Inc.
- SpheriTech Ltd.
- NuvOx Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Artificial Blood Substitute by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
- 2.2.3 Hemoglobin-based Oxygen Carrier (HBOC)
- 2.3 Artificial Blood Substitute by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Military
- 2.3.3 Civil
- 2.4 Assumptions and Limitations
3 Artificial Blood Substitute Breakdown Data by Type
- 3.1 Global Artificial Blood Substitute Historic Market Size by Type (2021-2026)
- 3.2 Global Artificial Blood Substitute Forecasted Market Size by Type (2027-2032)
4 Artificial Blood Substitute Breakdown Data by Application
- 4.1 Global Artificial Blood Substitute Historic Market Size by Application (2021-2026)
- 4.2 Global Artificial Blood Substitute Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Artificial Blood Substitute Market Perspective (2021-2032)
- 5.2 Global Artificial Blood Substitute Growth Trends by Region
- 5.2.1 Global Artificial Blood Substitute Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Artificial Blood Substitute Historic Market Size by Region (2021-2026)
- 5.2.3 Artificial Blood Substitute Forecasted Market Size by Region (2027-2032)
- 5.3 Artificial Blood Substitute Market Dynamics
- 5.3.1 Artificial Blood Substitute Industry Trends
- 5.3.2 Artificial Blood Substitute Market Drivers
- 5.3.3 Artificial Blood Substitute Market Challenges
- 5.3.4 Artificial Blood Substitute Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Artificial Blood Substitute Players by Revenue
- 6.1.1 Global Top Artificial Blood Substitute Players by Revenue (2021-2026)
- 6.1.2 Global Artificial Blood Substitute Revenue Market Share by Players (2021-2026)
- 6.2 Global Artificial Blood Substitute Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Artificial Blood Substitute Head Office and Area Served
- 6.4 Global Artificial Blood Substitute Players, Product Type & Application
- 6.5 Global Artificial Blood Substitute Manufacturers Established Date
- 6.6 Global Artificial Blood Substitute Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Artificial Blood Substitute Market Size (2021-2032)
- 7.2 North America Artificial Blood Substitute Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Artificial Blood Substitute Market Size by Country (2021-2026)
- 7.4 North America Artificial Blood Substitute Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Artificial Blood Substitute Market Size (2021-2032)
- 8.2 Europe Artificial Blood Substitute Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Artificial Blood Substitute Market Size by Country (2021-2026)
- 8.4 Europe Artificial Blood Substitute Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Artificial Blood Substitute Market Size (2021-2032)
- 9.2 Asia-Pacific Artificial Blood Substitute Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Artificial Blood Substitute Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Artificial Blood Substitute Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Artificial Blood Substitute Market Size (2021-2032)
- 10.2 South America Artificial Blood Substitute Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Artificial Blood Substitute Market Size by Country (2021-2026)
- 10.4 South America Artificial Blood Substitute Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Artificial Blood Substitute Market Size (2021-2032)
- 11.2 Middle East & Africa Artificial Blood Substitute Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Artificial Blood Substitute Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Artificial Blood Substitute Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aurum Biosciences Ltd.
- 12.1.1 Aurum Biosciences Ltd. Company Information
- 12.1.2 Aurum Biosciences Ltd. Business Overview
- 12.1.3 Aurum Biosciences Ltd. Revenue in Artificial Blood Substitute Business (2021-2026)
- 12.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Portfolio
- 12.1.5 Aurum Biosciences Ltd. Recent Developments
- 12.2 HEMARINA SA
- 12.2.1 HEMARINA SA Company Information
- 12.2.2 HEMARINA SA Business Overview
- 12.2.3 HEMARINA SA Revenue in Artificial Blood Substitute Business (2021-2026)
- 12.2.4 HEMARINA SA Artificial Blood Substitute Product Portfolio
- 12.2.5 HEMARINA SA Recent Developments
- 12.3 HbO2 Therapeutics
- 12.3.1 HbO2 Therapeutics Company Information
- 12.3.2 HbO2 Therapeutics Business Overview
- 12.3.3 HbO2 Therapeutics Revenue in Artificial Blood Substitute Business (2021-2026)
- 12.3.4 HbO2 Therapeutics Artificial Blood Substitute Product Portfolio
- 12.3.5 HbO2 Therapeutics Recent Developments
- 12.4 KaloCyte Inc.
- 12.4.1 KaloCyte Inc. Company Information
- 12.4.2 KaloCyte Inc. Business Overview
- 12.4.3 KaloCyte Inc. Revenue in Artificial Blood Substitute Business (2021-2026)
- 12.4.4 KaloCyte Inc. Artificial Blood Substitute Product Portfolio
- 12.4.5 KaloCyte Inc. Recent Developments
- 12.5 SpheriTech Ltd.
- 12.5.1 SpheriTech Ltd. Company Information
- 12.5.2 SpheriTech Ltd. Business Overview
- 12.5.3 SpheriTech Ltd. Revenue in Artificial Blood Substitute Business (2021-2026)
- 12.5.4 SpheriTech Ltd. Artificial Blood Substitute Product Portfolio
- 12.5.5 SpheriTech Ltd. Recent Developments
- 12.6 NuvOx Pharma
- 12.6.1 NuvOx Pharma Company Information
- 12.6.2 NuvOx Pharma Business Overview
- 12.6.3 NuvOx Pharma Revenue in Artificial Blood Substitute Business (2021-2026)
- 12.6.4 NuvOx Pharma Artificial Blood Substitute Product Portfolio
- 12.6.5 NuvOx Pharma Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst